Page last updated: 2024-10-22

amitriptyline and Uremia

amitriptyline has been researched along with Uremia in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yong, A1
Chong, WS1
Tey, HL1

Other Studies

1 other study available for amitriptyline and Uremia

ArticleYear
Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline.
    The Australasian journal of dermatology, 2014, Volume: 55, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Humans; Male; Middle Aged; Pruritus; Renal Insufficienc

2014